Population effects and variability

Methods in Molecular Biology

Volumn 929, Issue , 2012, Pages 521-581

  Dorne, Jean Lou ^a   Amzal, Billy ^b   Bois, Frédéric ^c,d   Crépet, Amélie ^e   Tressou, Jessica ^f   Verger, Philippe ^g  

^a EUROPEAN FOOD SAFETY AUTHORITY   (Italy)

^b London School of Hygiene Tropical Medicine   (United Kingdom)

^c UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^d INSTITUT NATIONAL DE L ENVIRONNEMENT INDUSTRIEL ET DES RISQUES INERIS   (France)

^e FRENCH AGENCY FOR FOOD   (France)

^f Department of Social Sciences   (France)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Benchmark dose; Cadmium; Dioxins; Dose reponse modeling; Meta analysis; Pathway related uncertainty factors; Physiologically based models; Population variability; Risk assessment; Systematic review; Toxicodynamics; Toxicokinetics

Indexed keywords

CHEMICAL COMPOUND; DRINKING WATER;

ARTICLE; COMPUTER PROGRAM; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; FOOD INTAKE; HEALTH HAZARD; INGESTION; INHALATION; POPULATION EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; SIMULATION; TOXICOKINETICS; TOXICOLOGY;

EID: 84934439491     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-50-2_20     Document Type: Article

References (95)

1. European Commission (EC) (2002) Regulation (EC) No 178/2002 of the european parliament and of the council laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety. http://eur-lex.europa.eu/ LexUriServ/LexUriServ.do?uri?OJ:L:2002:031:0001:0024:EN:PDF
2. WHO (2009) Principles and methods for the risk assessment of chemicals in food, Environmental health criteria 240. http://www.who.int/foodsafety/chem/ principles/en/index1.html
3. Svendsen C, Ragas AM, Dorne JLCM (2008) Contaminants in organic and conventional food: the missing link between contaminant levels and health effects. Book comparing organic vs non-organic food at the nutritional, microbiological and toxicological level. In: Givens DI et al (eds) Health benefits of organic foods: effects of the environment. Chapter 6, vol 119. CABI, Wallingford
4. Dorne JLCM, Bordajandi LR, Amzal B, Ferrari P, Verger P (2009) Combining analytical techniques, exspoure assessment and biological effects for risk assessment of chemicals in food. Trends Anal Chem 2009(28):695
5. Kroes R, Muller D, Lambe J, Lowik MR, van Klaveren J, Kleiner J, Massey R, Mayer S, Urieta I, Verger P, Visconti A (2002) Assessment of intake from the diet. Food Chem Toxicol 40(2-3):327-385
6. Dorne JCM (2010) Metabolism, variability and risk assessment. Toxicology 268 (3):156-164
7. EFSA (European Food Safety Authority) (2005) Opinion of the Scientific Committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic. EFSA J 282:1-31. http://www. efsa.europa.eu/EFSA/Scientific-Opinion/sc- op-ej282-gentox-en3.pdf
8. FAO/WHO (Food and Agriculture Organisation of the United Nations/World Health Organization) (2006) Safety evaluation of certain contaminants in food. Prepared by the Sixty-fourth meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). FAO Food Nutr Pap 82:1-778
9. EFSA (European Food Safety Authority) (2007) Opinion of the Scientific Panel on Contaminants in the Food chain on a request from the European Commission on ethyl carbamate and hydrocyanic acid in food and beverages. EFSA J 551:1-44. :http://www.efsa.europa. eu/cs/BlobServer/Scientific-Opinion/Conta m-ej551-ethyl-carbamate-en-rev.1.pdf?ssbi nary?true
10. EFSA (European Food Safety Authority) (2008) Scientific Opinion of the Panel on Contaminants in the Food Chain on a request from the European Commission on Polycyclic Aromatic Hydrocarbons in Food. EFSA J 724:1-114. http://www.efsa.europa.eu/cs/BlobServer/Scientific-Opinion/contam- ej-724-PAHs-en,1.pdf?ssbinary?true
11. EFSA (European Food Safety Authority) (2009) Scientific opinion on arsenic in food. EFSA J 7(10):1051. http://www.efsa.europa. eu/en/efsajournal/ doc/1351.pdf
12. JMPR (Joint FAO/WHO Meetings on Pesticide Residues) (2002) Report of the JMPR, FAO Plant Production and Protection Paper, 172, 4. FAO, Rome
13. EFSA (2009) Scientific opinion on marine biotoxins in shellfish-Palytoxin group. EFSA J 7 (12):1293. http://www.efsa.europa.eu/en/efsajournal/doc/1393. pdf
14. EFSA (2009) Potential risks for public health due to the presence of nicotine in wild mushrooms. EFSA J RN-286:2-47. http://www. efsa.europa.eu/en/ efsajournal/doc/286r.pdf
15. Renwick AG, Lazarus NR (1998) Human variability and noncancer risk assessment-an analysis of the default uncertainty factor. Regul Toxicol Pharmacol 27:3-20
16. WHO (2005) International Programme on Chemical Safety: chemical-specific adjustment. Factors for interspecies differences and human variability: guidance document for use of data in dose/concentration response assessment. World Health Organization, Geneva. http://www.who.int/ipcs/methods/harmonization/ areas/uncertainty/en/index.html
17. Amzal B, Julin B, Vahter M, Johanson G, Wolk A, Akesson A (2009) Population toxicokinetic modeling of cadmium for health risk assessment. Environ Health Perspect 117 (8):1293-1301
18. EFSA (European Food Safety Authority) (2009) Scientific Opinion of the Panel on Contaminants in the Food Chain on a request from the European Commission on cadmium in food. EFSA J 980:1-139. http://www.efsa. europa.eu/cs/BlobServer/Scientific-Opinion /contam-op-ej980-cadmium-en-rev.1. pdf? ssbinary?true
19. Dorne JLCM, Walton K, Renwick AG (2005) Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review. Food Chem Toxicol 43:203-216
20. Gerlowski LE, Jain RK (1983) Physiologically based pharmacokinetic modeling: principles and applications. J Pharm Sci 72:1103-1127
21. Bois F, Jamei M, Clewell HJ (2010) PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals. Toxicology 278:256-267
22. Gibaldi M, PerrierD(1982) Pharmacokinetics, 2nd edn, revised and expanded ed. Marcel Dekker, New York
23. Jamei M, Marciniak S, Feng KR, Barnett A, Tucker G, Rostami-Hodjegan A (2009) The Simcyp population-based ADME simulator. Expert Opin Drug Metab Toxicol 5:211-223
24. Bouvier d?Yvoire M, Prieto P, Blaauboer BJ, Bois FY, Boobis A, Brochot C, Coecke S, Freidig A, Gundert-Remy U, Hartung T, Jacobs MN, Lave T, Leahy DE, Lennernas H, Loizou GD, Meek B, Pease C, Rowland M, Spendiff M, Yang J, Zeilmaker M (2007) Physiologically-based kinetic modelling (PBK modelling): meeting the 3Rs agenda-the report and recommendations of ECVAM Workshop 63a. Altern Lab Anim 35:661-671
25. Edginton AN, Schmitt W, Willmann S (2006) Development and evaluation of a generic physiologically based pharmacokinetic model for children. Clin Pharmacokinet 45:1013-1034
26. Luecke RH, Pearce BA, Wosilait WD, Slikker W, Young JF (2007) Postnatal growth considerations for PBPK modeling. J Toxicol Environ Health A 70:1027-1037
27. Jones HM, Gardner IB, Watson KJ (2009) Modelling and PBPK simulation in drug discovery. AAPS J 11:155-166
28. Allen BC, Hack CE, Clewell HJ (2007) Use of Markov chain Monte Carlo analysis with a physiologically-based pharmacokinetic model of methylmercury to estimate exposures in US women of childbearing age. Risk Anal 27:947-959
29. Lorber M (2008) Exposure of Americans to polybrominated diphenyl ethers. J Expo Sci Environ Epidemiol 18(1):2-19
30. Fromme H, Korner W et al (2009) Human exposure to polybrominated diphenyl ethers (PBDE), as evidenced by data from a duplicate diet study, indoor air, house dust, and biomonitoring in Germany. Environ Int 35 (8):1125-1135
31. US-EPA (2003) Exposure and human health reassessment of 2,3,7,8-tetrachlorodibenzo-pdioxin (TCDD) and related compounds National Academy Sciences (NAS) review draft. Part III. EPA, Washington, DC
32. Pinsky PF, Lorber MN (1998) A model to evaluate past exposure to 2,3,7,8-TCDD. J Expo Anal Environ Epidemiol 8(2):187-206
33. Smith JC, Farris FF (1996) Methyl mercury pharmacokinetics in man: a reevaluation. Toxicol Appl Pharmacol 137(2):245-252
34. Albert I, Villeret G et al (2010) Integrating variability in half-lives and dietary intakes to predict mercury concentration in hair. Regul Toxicol Pharmacol 58(3):482-489
35. Delyon B, Lavielle M, Moulines E (1999) Convergence of a stochastic approximation version of the EM algorithm. Ann Stat 27(1):94-128
36. Rowland M, Benet LZ, Graham GG (1973) Clearance concepts in pharmacokinetics. J Pharmacokinet Biopharm 1:123-136
37. Shuey DL, Lau C, Logsdon TR, Zucker RM, Elstein KH, Narotsky MG, Setzer RW, Kavlock RJ, Rogers JM (1994) Biologically based doseresponse modeling in developmental toxicology: biochemical and cellular sequelae of 5- fluorouracil exposure in the developing rat. Toxicol Appl Pharmacol 126(1):129-144
38. Crump KS, Chen C, Chiu WA, Louis TA, Portier CJ et al (2010) What role for biologically based dose-response models in estimating lowdose risk? Environ Health Perspect 118(5
39. Crump KS (1984) A new method for determining allowable daily intakes. Fundam Appl Toxicol 4:854-871
40. Budtz-Jorgensen E, Keiding N, Grandjean P (2001) Benchmark dose calculation from epidemiological data. Biometrics 57:698-706
41. Sand S et al (2008) The current state of knowledge on the use of the benchmark dose concept in risk assessment. J Appl Toxicol 28 (4):405-421
42. Crump KS (2002) Critical issues in benchmark calculations from continuous data. Crit Rev Toxicol 32:133-153
43. Suwazono Y et al (2006) Benchmark dose for cadmium-induced renal effects in humans. Environ Health Perspect 114(7):1072-1076
44. Ryan L (2008) Combining data from multiple sources, with applications to environmental risk assessment. Stat Med 27:698-710
45. Wheeler MW, Bailer AJ (2007) Properties of model-averaged BMDLs: a study of model averaging in dichotomous response risk estimation. Risk Anal 27:659-670
46. Morales KH, Ibrahim JG, Chen CJ, Ryan LM (2006) Bayesian model averaging with applications to benchmark dose estimation for arsenic in drinking water. J Am Stat Assoc 101 (473):9-17
47. EC (2004) European Union System for the Evaluation of Substances 2.0 (EUSES 2.0). Prepared for the European Chemicals Bureau by the National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands (RIVM Report no. 601900005). Available via the European Chemicals Bureau. http://ecb.jrc.it
48. Bertail P, Clemencon S et al (2010) Statistical analysis of a dynamic model for dietary contaminant exposure. J Biol Dyn 4(2):212-234
49. Verger P, Tressou J, Clemencon S (2007) Integration of time as a description parameter in risk characterisation: application to methyl mercury. Regul Toxicol Pharmacol 49 (1):25-30
50. Tressou J, Leblanc JCh, Feinberg M, Bertail P (2004) Statistical methodology to evaluate food exposure to a contaminant and influence of sanitary limits: application to ochratoxin A. Regul Toxicol Pharmacol 40(3):252-263
51. Van den Berg M, Birnbaum L et al (1998) Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect 106:775-792
52. Thuresson, Hoglund et al (2000) In: Medicine and health policy. New York: Marcel Dekker
53. AFSSA (2009) Etude individuelle Nationale des consommations Alimentaires 2 (INCA 2) (2006-2007), Rapport AFSSA, 228p, http://www.anses.fr/Documents/ PASER-Ra- INCA2.pdf
54. EFSA (2010) Application of systematic review methodology to food and feed safety assessments to support decision making. EFSA J 8 (6):1637. http://www.efsa.europa.eu/en/efsajournal/doc/1637.pdf
55. Marvier M, McCreedy C, Regetz J, Kareiva P (2007) A meta-analysis of effects of Bt cotton and maize on nontarget invertebrates. Science 316(5830):1475-1477
56. Greenland S, Robins J (1994) Invited commentary: ecologic studies-biases, misconceptions, and counterexamples. Am J Epidemiol 139:747-60
57. Terrin N, Schmidt CH, Lau J, Olkin I (2003) Adjusting for publication bias in the presence of heterogeneity. Stat Med 22:2113-2212
58. Stangl D, Berry DA (eds) Meta-analysis
59. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in metaanalyses. BMJ 327:557-560
60. Egger M et al (2001) Systematic reviews in health care. BMJ books, London
61. Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
62. Biro G, Hulshof K, Ovesen L, Amorim Cruz JA (2002) Selection of methodology to assess food intake. Eur J Clin Nutr 56(Suppl 2): S25-S32. doi:10.1038/sj/ejcn/1601426
63. Verger P, Ireland J, Moller A, Abravicius JA, De Henauw S, Naska A (2002) Improvement of comparability of dietary intake assessment using currently available individual food consumption surveys. Eur J Clin Nutr 56(Suppl 2):S1-S7. doi:10.1038/sj/ejcn/1601425
64. Wirffalt E, Hedblad B, Gullberg B, Mattisson I, Andren CRU, Janzon L, Berglund G (2001) Food patterns and components of the metabolic syndrome in men and women: A cross-sectional study within the Malmo diet and cancer cohort. Am J Epidemiol 154(12):1150-1159
65. Zetlaoui M, Feinberg M, Verger P, Clemencon S (2011) Extraction of food consumption systems by non-negative matrix factorization (NMF) for the assessment of food choices. Biometrics (in press). http://hal.archivesouvertes. fr/docs/00/48/47/94/PDF/NMF- food.pdf
66. EFSA (2010) European Food Safety Authority; management of left-censored data in dietary exposure assessment of chemical substances. EFSA J 8(3):1557. http://www.efsa.europa. eu/en/efsajournal/doc/1557.pdf
67. Helsel DR (2005) Nondetects and data analysis. Wiley, New York
68. Kennedy MC, Roelofs VJ et al (2011) A hierarchical Bayesian model for extreme pesticide residues. Food Chem Toxicol 49(1):222-232
69. Tressou J, Bertail P et al (2003) 709 Evaluation of food risk exposure using extreme value theory-application to heavy metals for sea products consumers. Toxicol Lett 144(Supplement 1):s190
70. WHO (2009) Principles for modelling doseresponse for the risk assessment of chemicals. Environmental Health Criteria. http://www. who.int/tipcs/methods/ harmonization/dose-response/en/
71. Spilke J, Piepho HP,Hu X (2005) A simulation study on tests of hypotheses and confidence intervals for fixed effects in mixed models for blocked experiments with missing data. J Agric Biol Environ Stat 10:374-389
72. Spiegelhalter DJ, Best NG et al (2002) Bayesian measures of model complexity and fit. J R Stat Soc Series B Stat Methodol 64:583-640
73. Dorne JLCM, Walton K, Renwick AG (2001) Uncertainty factors for chemical risk assessment: human variability in the pharmacokinetics of CYP1A2 probe substrates. Food Chem Toxicol 39:681-696
74. Dorne JLCM, Walton K, Slob W, Renwick AG (2002) Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate? Food Chem Toxicol 40:1633-1656
75. Dorne JLCM, Renwick AG (2005) The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans. Toxicol Sci 86:20-26
76. Dorne JLCM, Walton K, Renwick AG (2003) Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors for risk assessment. Food Chem Toxicol 41:201-224
77. Dorne JLCM, Walton K, Renwick AG (2003) Polymorphic CYP2C19 and N-acetylation: human variability in kinetics and pathwayrelated uncertainty factors. Food Chem Toxicol 41:225-245
78. Kjellstrom T (1971) A mathematical model for the accumulation of cadmium in human kidney cortex. Nord Hyg Tidskr 52:111-119
79. Sutton AJ, Higgins JPT (2008) Recent developments in meta-analysis. Stat Med 27:625-650
80. Berry D, Strangl DK (eds) (2001) Metaanalysis in medicine and health policy. Biostatistics, New York
81. Morales KH, Ryan LM (2005) Benchmark dose estimation based on epidemiologic cohort data. Environmetrics 16:435-447
82. Lunn DJ, Thomas A, Best N, Spiegelhalter D (2000) WinBUGS-a Bayesian modelling framework: concepts, structure and extensibility. Stat Comput 10:325-337
83. EFSA (2011) Comparison of the approaches taken by EFSA and JECFA to establish a HBGV for cadmium. http://www.efsa.europa. eu/en/efsajournal/doc/ 2006.pdf.
84. Suwazono Y, Nogawa K, UetaniMet al (2011) Application of hybrid approach for estimating the benchmark dose of urinary cadmium for adverse renal effects in the general population of Japan. J Appl Toxicol 31(1):89-93
85. Tard A, Gallotti S, Leblanc JC, Volatier JL (2007) Dioxins, furans and dioxin-like PCBs: occurrence in food and dietary intake in France. Food Addit Contam 24(9):1007-1017
86. Milbrath MO, Wenger Y, Chang CW, Emond C, Garabrant D, Gillespie BW, Jolliet O (2009) Apparent half-lives of dioxins, furans, and polychlorinated biphenyls as a function of age, body fat, smoking status, and breast-feeding. Environ Health Perspect 117(3):417-425
87. Gray LE, Ostby JS et al (1997) A doseresponse analysis of the reproductive effects of a single gestational dose of 2,3,7,8-tetrachlorodibenzo- p-dioxin in male Long Evans Hooded rat offspring. Toxicol Appl Pharmacol 146(11-20)
88. Bokkers, B. G. H., M. J. Zeilmaker, et al. (2009). RIVM report on framework and integration methods. The application of animal toxicity data in risk-benefit analysis: 2,3,7,8-TCDD as an example.
89. Bernillon P, Bois FY (2000) Statistical issues in toxicokinetic modeling: a Bayesian perspective. Environ Health Perspect 108(Suppl 5):883-893
90. Yan L, Sheihk-Bahaei S, Park S, Ropella GE, Hunt CA (2008) Predictions of hepatic disposition properties using a mechanistically realistic, physiologically based model. Drug Metab Dispos 36(4):759-768
91. Lerapetritou MG, Georgopoulos PG, Roth CM, Androulakis LP (2009) Tissue-level modeling of xenobiotic metabolism in liver: an emerging tool for enabling clinical translational research. Clin Transl Sci 2(3):228-237
92. McDonald TA (2005) Polybrominated diphenylether levels among United States residents: daily intake and risk of harm to the developing brain and reproductive organs. Integr Environ Assess Manag 1(4):343-354
93. Van der Molen GW, Kooijman SALM et al (1996) A generic toxicokinetic model for persistent lipophilic compounds in humans: an application to TCDD. Fundam Appl Toxicol 31(1):83-94
94. Verner MA, Ayotte P et al (2009) A physiologically based pharmacokinetic model for the assessment of infant exposure to persistent organic pollutants in epidemiologic studies. Environ Health Perspect 117(3):481-487
95. Lu C, Holbrook CM et al (2010) The implications of using a physiologically based pharmacokinetic (PBPK) model for pesticide risk assessment. Environ Health Perspect 118 (1):125-130